Mark Zuckerman
Overview
Explore the profile of Mark Zuckerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1305
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuckerman M, Lampejo T, Smith M
J Infect Dis
. 2024 Nov;
230(6):1299-1301.
PMID: 39506609
As pathogen molecular diagnostics technology develops, the software analysis of polymerase chain reaction sigmoidal curves, cycle threshold (Ct) values, and the limit of nucleic acid detection for that assay is...
2.
Reis de Andrade J, Scourfield E, Peswani-Sajnani S, Poulton K, Ap Rees T, Khooshemehri P, et al.
Biol Methods Protoc
. 2024 Jul;
9(1):bpae046.
PMID: 38993523
Rapid and accessible testing was paramount in the management of the COVID-19 pandemic. Our university established KCL TEST: a SARS-CoV-2 asymptomatic testing programme that enabled sensitive and accessible PCR testing...
3.
Varmpompiti K, Westwood A, Ben-Joseph A, Sibtain N, Ibrahim M, Stanton B, et al.
J Neuroimmunol
. 2023 Nov;
385:578248.
PMID: 37995595
Background: Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease due to a lytic infection of oligodendrocytes caused by John Cunningham polyoma virus (JCV) infection. Idiopathic CD4+ T-cell lymphocytopenia (ICL)...
4.
Lazana I, Apap Mangion S, Babiker S, Large J, Trikha R, Zuckerman M, et al.
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298309
Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by hemolysis and thrombosis and is associated with significant morbidity and mortality. Although complement inhibitors have significantly changed the outcomes in PNH patients, breakthrough...
5.
Cirillo C, Nakou E, Georgiopoulos G, Tountas C, Victor K, Marvaki A, et al.
BMJ Open
. 2022 Dec;
12(12):e059358.
PMID: 36456009
Objectives: The aim of this study was to investigate the relationship of echocardiographic parameters, laboratory findings and clinical characteristics with in-hospital mortality in adult patients with COVID-19 admitted to the...
6.
Potential pitfalls in analysing a SARS-CoV-2 RT-PCR assay and how to standardise data interpretation
Smith M, El Bouzidi K, Bengen S, Cohen A, Zuckerman M
J Virol Methods
. 2022 Jul;
308:114589.
PMID: 35878653
The emergence of SARS-CoV-2 in December 2019 lead to the rapid implementation of assays for virus detection, with real-time RT-PCR arguably considered the gold-standard. In our laboratory Altona RealStar SARS-Cov-2...
7.
Jimenez-Guardeno J, Ortega-Prieto A, Menendez Moreno B, Maguire T, Richardson A, Diaz-Hernandez J, et al.
PLoS Comput Biol
. 2022 Jul;
18(7):e1010330.
PMID: 35849631
The COVID-19 pandemic has accelerated the need to identify new antiviral therapeutics at pace, including through drug repurposing. We employed a Quadratic Unbounded Binary Optimization (QUBO) model, to search for...
8.
Banatvala J, Muir P, Irving W, Zuckerman M
BMJ
. 2022 May;
377:o1168.
PMID: 35534037
No abstract available.
9.
Page R, Scourfield E, Ficarelli M, McKellar S, Lee K, Maguire T, et al.
STAR Protoc
. 2022 Apr;
3(2):101300.
PMID: 35479118
The gold standard protocol for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection detection remains reverse transcription quantitative polymerase chain reaction (qRT-PCR), which detects viral RNA more sensitively than any...
10.
Page R, Scourfield E, Ficarelli M, McKellar S, Lee K, Maguire T, et al.
Cell Rep Methods
. 2022 Mar;
2(3):100186.
PMID: 35262039
Management of COVID-19 and other epidemics requires large-scale diagnostic testing. The gold standard for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains reverse transcription quantitative PCR (qRT-PCR) analysis, which...